An efficacy, safety, and tolerability study of canagliflozin in patients with type 2. Diabetes mellitus who have moderate renal impairment

Authors
Category Primary study
Year 2013
This article has no abstract
Epistemonikos ID: d3ad6900452aeed3b0f21c19bac40759f6561ee3
First added on: Nov 09, 2018